Invex Therapeutics sees best day in 6 months on European patent grant

Invex Therapeutics

16/08/2021 06:11

** Shares of biopharma firm Invex Therapeutics  IXC.AX  rise
as much as 11.1% to A$0.7, marking their biggest intraday pct
gain since Feb. 11
    ** Co says it has been granted a European patent for 
Presendin, its drug for neurological conditions relating to
raised intracranial pressure, by the European Patent Office 
 urn:newsml:reuters.com:*:nASX25QcRl
    ** Stock hits highest since May 28
    ** Over 140,000 shares change hands, vs 30-day average
volume of ~37,000
    ** Stock down ~12% YTD, as of last close

 (Reporting by Arundhati Dutta in Bengaluru)
 ((Arundhati.Dutta@thomsonreuters.com;))